bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.08.06.743332

An Aging Risk-Factor Scale: Biomarkers of Renal Disease and Anemia are Primary Predictors of Three-Year Survival in Common Marmosets (Callithrix jacchus)

Abstract

Valid animal models are needed to evaluate how age-related changes in kidney function influence healthspan. Aging marmosets frequently develop renal insufficiency with anemia and exhibit reductions in body mass and metabolic rate. However, it remains unclear which age-related changes predict survival and which thresholds indicate increased mortality risk. We prospectively evaluated age, body composition, resting energy expenditure, hematology, and blood chemistry as predictors of 3-year survival in female and male marmosets (n = 66), 2-16 years of age. Objectives were to identify prognostic markers, define high-risk thresholds, and to develop and test a composite risk-factor scale for mortality screening in captivity. A 10-variable model showed the best predictive performance in multivariable Cox proportional hazards modeling, and was retained for further analysis (concordance = 0.881, p < 0.001). ROC curves using Youdens Index and AUC identified high-risk thresholds for predictors in the multivariable model, and threshold-defined categories were evaluated by Kaplan-Meier survival analysis. The 10 binary risk-factors were combined into a composite scale scored from 0 to 10 and tested with Cox regression. The scale explained approximately 42% of variance in survival and each additional risk factor increased mortality risk 1.75-fold (95% CI: 1.43-2.14, p < 0.001). Marmosets with [&ge;]7 risk factors exhibited a 19-month reduction in survival, and this high-risk threshold predicted 3-year survival with 89.4% accuracy. Results support the scale as a screening tool for mortality risk and highlight the high prevalence of age-associated renal disease and anemia in marmosets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Arroyo, J. P., Mustoe, A. C., Reveles, K. R., Brasky, K. M., Perry, D., Cervantes, L., Alvarez, A., Hinojosa, C., Greig, J., Hickmott, A. J., Ridenhour, B. J., Amato, K. R., Power, M. L., Ross, C. N.. 2026-08-12. An Aging Risk-Factor Scale: Biomarkers of Renal Disease and Anemia are Primary Predictors of Three-Year Survival in Common Marmosets (Callithrix jacchus). https://doi.org/10.64898/2026.08.06.743332

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗